Moolec Science (MLEC) Revenue (2023 - 2024)

Moolec Science's (MLEC) quarterly Revenue came in at $2.6 million in Q4 2024, up 948.32% year-on-year from $252114.0 in Q1 2024, and up 69.75% quarter-over-quarter from $1.6 million in Q3 2024.

Moolec Science (MLEC) Revenue (2023 - 2024) Analysis & Trends

Moolec Science has disclosed Revenue across 2 years of filings, most recently posting $2.6 million for Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 5.21 Mn
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn 306.30 Mn
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 2.99 Bn
9 Abivax 94.26 Bn 94.26 Bn - -
10 Moolec Science 6.98 Bn 6.98 Bn - -

Historic Data

Download Data
DateValue
Dec 31, 2024 2.64 Mn
Sep 30, 2024 1.56 Mn
Mar 31, 2024 2.11 Mn
Dec 31, 2023 252,114.00
Sep 30, 2023 1.74 Mn